Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Current Evidence Using Pulsed Electromagnetic Fields in Osteoarthritis: A Systematic Review
Submission received: 25 February 2024 / Revised: 22 March 2024 / Accepted: 25 March 2024 / Published: 28 March 2024
In a randomized controlled trial by Bagnato et al., utilizing the Bioelectronics Corporation’s PEMF device for 12 h daily over one month in knee osteoarthritis patients, a significant reduction in pain intensity emerged as the primary outcome [27]. This improvement was coupled with enhancements in quality of life and an increased pain threshold in response to pressure.
https://www.mdpi.com/2077-0383/13/7/1959
Pretty sure BIEL has to report full year numbers…
Everybody should read this this is some crazy news
https://www.cnn.com/2024/03/25/health/fda-ban-electrical-stimulation-devices/index.html
Tom Oxley to Keynote the 2024 Bioelectronic Medicine Forum in New York City
Neurotech Reports 1 hr ago
https://www.send2press.com/wire/tom-oxley-to-keynote-the-2024-bioelectronic-medicine-forum-in-new-york-city/
Keith gone…other than on the board of BIEL.
Bioelectronic medicine is a big shift in philosophy.
Once accepted by the medical community, things will change .
PEMF helps blood flow and increased blood flow brings oxygen which reduces inflammation. That recipe does good for many health issues.
Sleepy Art!
What does your posts have in common with the State of the Union last night?
Lol!
“Testy”
It called me dishonest so I responded.
With that said…….4Q
“That for being so totally dishonest about this junk company.”
Who you call dishonest you low life POS?
Might be old?
Got an hour of sitting around…let’s see if I find anything new.
AdvaMed strongly supports creation of an alternative, expedited pathway to coverage and payment for emerging devices and diagnostics. Transitional coverage for these technologies would bolster the innovation ecosystem and provide Medicare patients’ swift access to new technologies that existing therapies may be unable to address. A recent study by the Stanford Byers Center for Biodesign found it takes an average of five years for medical technologies to achieve nationwide coding, coverage, and payment. This delay not only impacts patients, but also increases costs, which flow through the entire healthcare system.
The Centers for Medicare & Medicaid Services (CMS) is working with industry stakeholders, including medical device companies, as well as physician societies and patient groups to develop an alternate pathway called Transitional Coverage for Emerging Technologies (TCET).
https://www.advamed.org/about/initiatives/
Didn’t they say that a deal fell through in the last chairman of the board update?
Keep it up GG!
Good stuff!!
FDA approved non-opioid pain management approaches in all outpatient surgical settings.
Recoveryrx!!!! FDA approved
The NOPAIN Act will increase the use of non-opioid pain management approaches by changing outdated federal reimbursement policies. The policy will:
Expand patient and provider access to FDA approved non-opioid pain management approaches in all outpatient surgical settings.
Require a report to Congress on limitations, gaps, barriers to access, or deficits in Medicare coverage or reimbursement for therapeutic services.
The NO PAIN Act changes this policy by directing the Centers for Medicare and Medicaid Services to provide separate Medicare reimbursement for non-opioid treatments used to manage pain in both the hospital outpatient department and the ambulatory surgery center settings.
Pulsed Electromagnetic Fields for Postoperative Analgesia: A Randomized, Triple-Masked, Sham-Controlled Pilot Study
a study on Postoperative Pain Pain
Therefore, it has the potential to concurrently improve analgesia and decrease or even negate opioid requirements, only without the limitations of opioids and peripheral nerve blocks.
https://clinicaltrials.ucbraid.org/trial/NCT05399355
What is the Status of the NOPAIN Act? The NOPAIN Act was passed in an end-of-year legislative package in the 117th Congress in 2022. As a result of the law, patients and providers will have expanded access to non-opioids starting in 2025.
Amen Miamifl!!
Testing 1 2 3!
Go BIEL!
Extremity Trauma and Amputation Center of Excellence
The EACE leads the advancement of extremity trauma related discovery and clinical practice to optimize outcomes of service members, veterans, and beneficiaries while meeting the needs of the Combatant Commands and the Military Health System. The EACE is committed to ensuring a better future for those with extremity trauma. Established by the 2009 National Defense Authorization Act, the EACE is established jointly between the Department of Defense and the Department of Veterans Affairs.
The EACE was originally established to operate with the U.S. Army as its lead component. In October 2022 the EACE aligned to the Defense Health Agency in the Research & Engineering Directorate with the other Congressionally established Centers of Excellence.
https://health.mil/Military-Health-Topics/Centers-of-Excellence/EACE?type=Fact+Sheets
There she blows!
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
DEVICESNEUROLOGICAL
By NS Medical Staff Writer 26 Feb 2024
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
Someone’s a little bit sensitive!
Go Biel!
Your desperate!
Life is more than just money! Clearly your obsession with BIEL is unhealthy.
Put on an ActiPatch and see how it work on phantom brain.
Go BIEL!
Getting under your skin?
Lol!
Straight from the last update!
SALES
Company representatives attended the Modern Musculoskeletal Care Symposium this past weekend in Columbus, Ohio. We were once again invited to exhibit and Dr. Berend spoke to the medical professionals in attendance about “Non Thermal Pulsed Shortwave Therapy for Pre and Post Op Pain” Our attendance at the show was predicated on the expectation that the use of RecoveryRx will expand through the OrthoAlliance (https://orthoalliance.com/) organization in the next few months.
Thank you TeamBIEL!
Keep going you got this!!
The Recovery Pathway
Recovery Rx
A medical device that uses pulsed electromagnetic therapy to reduce pain and inflammation (not implanted).
https://orthoalliance.com/solutions-for-optimal-patient-outcomes/